Blog

  • Turning Cancer Data into Action: NCI-K Champions Mandatory Cancer Reporting at the 9th Kenya International Cancer Conference.

    Turning Cancer Data into Action: NCI-K Champions Mandatory Cancer Reporting at the 9th Kenya International Cancer Conference.

    MOMBASA, KENYA — November 19, 2026 — The NATIONAL CANCER INSTITUTE OF KENYA (NCI-K) has called upon all public and private healthcare facilities across the country to uphold their statutory duty of mandatory cancer reporting, emphasizing that verified, real-world data is the cornerstone of effective cancer control and patient survival.

    Delivering a keynote presentation on the opening day of the 9th Kenya International Cancer Conference (KICC 2026)—hosted by the Kenya Society of Haematology & Oncology (KESHO) in Mombasa- Mrs. Gladys Chesumbai , Head of the National Cancer Registry at NCI-K, highlighted the urgent need to bridge the gap between clinical diagnosis and national policy.

    Speaking in alignment with the conference theme, “Equity, Excellence, and Sustainable Impact in Cancer Care,” Mrs. Chesumbai outlined how comprehensive cancer surveillance powers Kenya’s National Cancer Control Strategy (2023–2027).

    Cancer Control Begins with Knowing the Burden

    Guided by the strategic thesis that “a country cannot plan an effective response to a burden it cannot see clearly,” NCI-K’s National Cancer Registry operates on a three-pillar framework:

    • SEE: Identifying exact cancer types by geographic location and population demographics.
    • UNDERSTAND: Uncovering disease patterns, service delivery gaps, and healthcare inequities across counties.
    • ACT: Aligning national health policy, clinical services, and targeted investments—such as the Social Health Authority (SHA) Enhanced Cancer Benefits Package—to meet actual population needs.

    Kenya’s Cancer Landscape: Insights from Registry & GLOBOCAN Data

    During her presentation, Mrs. Chesumbai shared critical epidemiological insights highlighting where Kenya’s cancer burden is most concentrated:

    Article content
    Top Five Cancer Data Presentation
    • Top Five Cancers Drive Over Half of All Cases: According to GLOBOCAN 2024 incidence and mortality data presented at the forum, five cancers account for 52.3% of all cancer cases in Kenya: Breast Cancer: 16.2% (6,822 new cases; 2,882 annual deaths) Cervical Cancer: 12.0% (4,294 new cases; 2,606 annual deaths) Prostate Cancer: 10.0% (3,661 new cases; 2,136 annual deaths) Oesophageal Cancer: 7.1% (2,532 new cases; 2,353 annual deaths) Colorectal Cancer: 7.0% (2,525 new cases; 1,411 annual deaths)
    • County-Level Surveillance: Data from the 2024 national registry tracking illustrates how mapping cases by county of residence—led by Nairobi (1,428 cases), Kiambu (947), Nakuru (854), Nyeri (844), and Meru (841)—enables health authorities to identify high-burden regions and tailor county-level interventions.

    A Statutory National Responsibility

    Mrs. Chesumbai reminded clinicians, pathologists, laboratory specialists, and hospital administrators that cancer notification is not optional. Under the Cancer Prevention and Control Act (2012), Cap. 246B, cancer reporting is mandatory across all health facilities in Kenya.

    To achieve a truly comprehensive National Cancer Registry, NCI-K is enforcing four key operational standards:

    Article content
    Statutory Responsibility Presentation
    • Universal Coverage: A binding reporting duty across both public and private health facilities.
    • Seamless Pathways: Establishing direct digital and operational links from diagnosis to capture in the National Cancer Registry.
    • Multidisciplinary Alignment: Ensuring coordinated reporting among attending clinicians, pathologists, and diagnostic laboratories.
    • System Accountability: Maintaining audited quality standards for complete, accurate, and timely data submission.

    Translating Evidence into Lifesaving Impact

    Concluding her address on “From Cancer Data to Decisions That Save Lives,” Mrs. Chesumbai demonstrated how verified registry evidence directly informs on-the-ground action:

    1. Policy & Priorities: Guiding targeted community screening and early detection outreach for high-burden cancers across counties.
    2. Planning & Investment: Supporting the equitable deployment and equipping of regional cancer centers across the country.
    3. Accountability & Survivorship: Tracking treatment outcomes and measurable survival gains over time to improve cancer survivors’ quality of life.

    As KICC 2026 continues in Mombasa through November 21, the National Cancer Institute of Kenya remains committed to collaborating with healthcare providers, researchers, county governments, and development partners to strengthen cancer surveillance and build a healthier, cancer-free nation.

  • NCI-K HOSTS JICA AND KPMG JAPAN DELEGATION TO EXPLORE STRATEGIC COLLABORATION IN CANCER PREVENTION AND CONTROL IN KENYA.

    NCI-K HOSTS JICA AND KPMG JAPAN DELEGATION TO EXPLORE STRATEGIC COLLABORATION IN CANCER PREVENTION AND CONTROL IN KENYA.

    The NATIONAL CANCER INSTITUTE OF KENYA (NCI-K) hosted a delegation from the Japan International Cooperation Agency (JICA), comprising Ms. Kaneko Nae and Ms. Sachiko Namba, alongside representatives from KPMG Japan, Ms. Yukiko Ogura and Mr. Koya Hatakeyama, for a strategic engagement aimed at exploring opportunities for collaboration in addressing Kenya’s growing cancer burden.

    The visit provided an important platform for dialogue, knowledge exchange and brainstorming on potential areas of cooperation between NCI-K, JICA and KPMG Japan, with a shared commitment to strengthening Kenya’s cancer prevention and control ecosystem.

    Article content
    Mr. Koya Hatakeyama, Manager, Advisory Services Division (KPMG), Signing the Visitor’s Book

    Discussions focused on identifying innovative approaches to addressing the increasing incidence of cancer in Kenya, particularly through strengthening prevention and screening, early detection, diagnosis, access to quality cancer care, research, data systems and institutional capacity. The engagement also explored opportunities for leveraging Japan’s experience, technical expertise, technological advancements and best practices in cancer prevention and control to support Kenya’s national priorities.

    The delegation and NCI-K team explored potential areas of collaboration, including:

    Strengthening Cancer Prevention and Early Detection by supporting innovative approaches to public awareness, cancer education, risk reduction, population-based screening and early diagnosis to reduce late-stage cancer presentation.

    Capacity Building and Knowledge Exchange through facilitating technical cooperation, institutional partnerships, professional development and exchange programmes to strengthen the capacity of Kenya’s healthcare workforce in cancer control.

    Cancer Data, Research and Digital Innovation. Exploring opportunities to strengthen cancer surveillance, cancer registries, data management systems, digital health solutions and evidence-informed decision-making.

    Strengthening Cancer Care Systems. Identifying opportunities to improve coordination across the cancer care continuum, including diagnosis, treatment, survivorship and palliative care.

    Article content

    Technology Transfer and Innovation. Exploring the potential application of Japanese technological innovations, expertise and solutions in strengthening cancer prevention, diagnostics, health information management and service delivery.

    Strategic Partnerships and Resource Mobilisation. Identifying opportunities for joint initiatives, technical assistance, investment partnerships and resource mobilisation to support the implementation of Kenya’s cancer prevention and control priorities.

    During the engagement, NCI-K highlighted its statutory mandate under the Cancer Prevention and Control Act, 2012, as the national institution responsible for coordinating and providing leadership in  cancer prevention and control in Kenya. The Institute underscored the importance of strategic partnerships in complementing government efforts, mobilising resources, strengthening institutional capacity and accelerating the implementation of national cancer control interventions.

    Article content

    The engagement reaffirmed the importance of international cooperation in addressing the complex and multifaceted cancer challenge. It also provided an opportunity to consider how the complementary expertise of JICA, KPMG Japan and NCI-K could be harnessed to develop practical, scalable and sustainable interventions that respond to Kenya’s cancer control priorities.

    NCI-K welcomed the engagement and expressed optimism that the discussions would provide a foundation for a mutually beneficial partnership that leverages Japan’s technical expertise and international development experience to strengthen Kenya’s cancer prevention and control agenda.

  • Government Cancer Treatment Centres in Kenya: Where Can Patients Access Cancer Care?

    Government Cancer Treatment Centres in Kenya: Where Can Patients Access Cancer Care?

    Access to cancer care is a key step toward improving cancer outcomes in Kenya. As the country continues to strengthen its cancer prevention, early detection, diagnosis, and treatment services, several government hospitals are providing oncology services to patients across different regions.

    Through national referral hospitals, teaching and referral hospitals, and county referral facilities, the public health system is progressively expanding access to cancer services closer to where people live.

    This article is intended to help patients, caregivers, and families affected by cancer to know where these services are available, thus, enabling them to make informed decisions about screening, diagnosis, treatment and follow-up care.

    Major Government Cancer Treatment Centres in Kenya

    Kenya has several public health facilities providing specialized cancer care. These include:

    1. National Referral and Teaching Hospitals

    These facilities play a significant role in providing specialized and comprehensive cancer management services.

    • Kenyatta National Hospital (KNH) – Nairobi: One of Kenya’s leading public referral hospitals, offering specialized oncology services, including cancer diagnosis and treatment.
    • Kenyatta University Teaching, Referral and Research Hospital (KUTRRH) – Nairobi: Hosts the Chandaria Comprehensive Cancer Centre, which provides specialized cancer care.
    • Moi Teaching and Referral Hospital (MTRH) – Eldoret: A major public referral facility serving patients from western Kenya, the North Rift and neighbouring regions, with specialized cancer management services.

    2. Regional and County Referral Hospitals

    Several county and regional referral hospitals also provide cancer-related services, helping improve access to care outside Nairobi and other major urban centres.

    These include:

    HospitalCounty
    Coast General Teaching and Referral HospitalMombasa
    Garissa County Referral HospitalGarissa
    Nakuru County Referral HospitalNakuru
    Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH)Kisumu
    Kakamega County Teaching and Referral HospitalKakamega
    Nyeri County Referral HospitalNyeri
    Embu County Referral HospitalEmbu
    Meru County Referral HospitalMeru
    Machakos County Referral HospitalMachakos
    Longisa County Referral HospitalBomet

    Additional public facilities, including Mbagathi County Referral Hospital in Nairobi and Kisii Teaching and Referral Hospital in Kisii, are also important in the expansion of regional cancer services.

    Available Cancer Services For Patients

    The range of cancer services differs from one hospital to another. Depending on the facility’s capacity, patients may access:

    1. Cancer screening and early detection

    Screening services help identify certain cancers and precancerous conditions before symptoms develop. Examples include cervical, breast, and colorectal cancer screening, depending on the facility.

    2. Cancer diagnosis

    Diagnostic services may include clinical examinations, imaging, laboratory investigations, and tissue biopsy to establish whether a patient has cancer and determine the type and stage.

    3. Chemotherapy

    Some public referral hospitals provide chemotherapy services, which use medicines to destroy cancer cells or control their growth.

    4. Cancer surgery

    Selected referral hospitals offer surgical procedures to remove cancerous tumours and manage certain cancer-related complications.

    5. Radiotherapy

    Radiotherapy uses high-energy radiation to destroy cancer cells. It requires specialised equipment and trained personnel and is available in selected facilities.

    6. Palliative and supportive care

    Palliative care helps improve the quality of life of people living with cancer by managing pain, symptoms and other physical, psychological, social and spiritual needs.

    Patients should confirm the availability of specific services with their preferred hospital before travelling or making referral arrangements.

    Strengthening Access to Cancer Care Across Kenya

    The National Cancer Institute of Kenya (NCI-K) plays an important role in coordinating and strengthening cancer prevention and control efforts in the country.

    Through policy implementation, coordination, partnerships, research promotion, advocacy, and public awareness, NCI-K supports national efforts to improve cancer outcomes and strengthen access to quality cancer services.

    Improving awareness of available cancer treatment facilities is one way of helping patients, caregivers and communities navigate the cancer care system.

    Currently, NCI-K is pushing for an accelerated expansion of cancer centres beyond the major national referral hospitals, which is essential to improving access and reducing the financial and geographical burden experienced by patients and their families.

    Regional and county referral hospitals play an important role in decentralizing cancer services, supporting early diagnosis, facilitating treatment and ensuring continuity of care. Currently, NCI-K is working on the County Cancer Control Framework, a strategic collaboration aimed at ensuring continuity of cancer services in the counties.

    Strengthening these facilities requires investment in diagnostic equipment, treatment infrastructure, specialized health workers, medicines, patient support systems and referral networks. Collaboration between national and county governments, health institutions, research organizations, development partners and other stakeholders remains important in advancing cancer prevention and control.

  • NCI-K Leads National Efforts to Integrate Comprehensive Cancer Education into Health Professional Training in Kenya.

    NCI-K Leads National Efforts to Integrate Comprehensive Cancer Education into Health Professional Training in Kenya.

    The National Cancer Institute of Kenya (NCI-K) has convened a two-day National Consultative Workshop aimed at strengthening cancer education in pre-service health professional training programmes across the country.

    Held from 10–11 November 2026, the workshop brought together stakeholders to deliberate on ways of integrating comprehensive cancer education into the curricula of health professional training institutions, ensuring that future healthcare workers are adequately equipped with the knowledge and competencies needed to address the growing cancer burden in Kenya.

    Participants and stakeholders during the two-day national workshop on integrating comprehensive cancer education into health professional training programmes in Kenya.

    Dr. Lucy Musyoka, Director of Standards and Regulation at the Ministry of Health, represented Ms. Mary Muthoni Muriuki, Principal Secretary, State Department for Public Health and Professional Standards, at the workshop.

    Dr. Lucy Musyoka, Director of Standards and Regulation at the Ministry of Health, addressing participants.

    The consultative forum sought to establish a shared understanding of the national case for comprehensive cancer education, assess existing institutional provisions, identify essential graduate competencies and explore practical opportunities for integrating cancer education into existing training curricula.

    Discussions on the first day focused on Kenya’s cancer control priorities, the National Cancer Control Strategy, cancer data and surveillance, research, and the role of the health workforce in addressing cancer. Participants also examined the proposed institutional self-assessment tool, which will help establish the current status of cancer education, identify gaps, and highlight opportunities for improvement within training institutions.

    A key component of the discussions was identifying what every graduating health professional should understand about cancer, regardless of their area of specialization. This included the importance of cancer prevention, risk reduction, early detection, timely referral, patient management and evidence-based practice.

    The second day focused on reviewing institutional findings, validating the proposed cancer education framework and identifying practical approaches to curriculum integration. Stakeholders also examined eight proposed cancer education modules, minimum common competencies and a proposed Core/Basic curriculum matrix.

    The workshop further explored the Institute’s mandate in setting standards, strengthening quality assurance, supporting cancer research and data systems, and advancing national cancer prevention and control efforts.

    Speaking during the engagement, NCI-K Chief Executive Officer, Dr. Elias Melly, provided leadership in framing the workshop’s objectives and guiding discussions on the national priorities for strengthening cancer education.

    The consultations also provided an opportunity for training institutions to identify implementation challenges, including curriculum ownership, faculty capacity, clinical exposure, availability of learning resources, and assessment approaches.

    The expected outcomes include stakeholder-informed recommendations on the proposed cancer education framework, institution-specific proposals for curriculum integration and a consolidated action plan outlining priority interventions, responsible parties, supporting partners and indicative implementation timelines.

    Through this initiative, NCI-K seeks to promote a more coordinated and comprehensive approach to cancer education, ensuring that health professionals entering the workforce are better prepared to contribute to cancer prevention, early diagnosis, quality care, and improved patient outcomes.

    Towards a Cancer-Free Nation.

  • Dr. Elias Melly Opens First Scientific Medical Physics Conference, Calls for Stronger Collaboration in Cancer Care.

    Dr. Elias Melly Opens First Scientific Medical Physics Conference, Calls for Stronger Collaboration in Cancer Care.

    The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, has presided over the opening of the 1st Scientific Medical Physics Conference and the launch of the Association of Medical Physicists in Kenya (AMPKen), held from 5th to 7th November 2026 at the Nairobi Hospital Convention Centre, Nairobi.

    NCI-K CEO, Dr. Elias Melly, presiding over the opening of the 1st Scientific Medical Physics Conference in Nairobi.

    The conference, themed “Advancing Equitable Cancer Care in Kenya: The Role of Medical Physicists in Radiation Medicine and Safety,” brought together stakeholders in medical physics and cancer care to discuss strengthening medical physicists’ contribution to quality, safe, and equitable cancer services.

    In his address, Dr. Melly highlighted the critical role medical physicists play in cancer diagnosis and treatment, particularly in radiation medicine, medical imaging and radiation safety. He highlighted the importance of capacity building, research, innovation and quality assurance in strengthening Kenya’s cancer care system.

    Dr. Melly reaffirmed NCI-K’s commitment to working closely with AMPKen to advance shared priorities, noting that medical physicists are integral to the delivery of safe, effective and quality cancer care. He pledged to foster collaboration between the two institutions to strengthen professional capacity, promote research, and enhance quality assurance in cancer diagnosis and treatment.

    The conference provides an important platform for knowledge exchange and collaboration, with discussions spanning cancer burden and health equity, clinical medical physics practice, precision medicine, radiotherapy, diagnostic imaging, nuclear medicine, artificial intelligence, infrastructure development, research and workforce development.

    The launch of AMPKen marks an important step towards strengthening the professional community of medical physicists in Kenya and advancing their contribution to the country’s cancer prevention, diagnosis and treatment agenda.

    Through strategic partnerships and sustained investment in specialised healthcare professionals, NCI-K remains committed to advancing quality, accessible, and equitable cancer care towards a cancer-free nation.

  • Breast Cancer in Men: Chrisantus Bundi Shares His Journey as a Survivor.

    Breast cancer is often perceived as a disease that affects women. However, men can also develop breast cancer, although cases among men are rare. For Chrisantus O. Bundi, a breast cancer survivor, sharing his personal experience is an opportunity to challenge misconceptions, raise awareness, and remind the public that cancer does not discriminate by gender.

    Chrisantus Bundi Sharing his Story During the Breast Cancer Awareness Month Commemoration.

    Bundi shared his breast cancer survival story during the commemoration of Breast Cancer Awareness Month in Nyamira County yesterday, where he spoke about his experience as a man who has faced the disease and emerged as a survivor. His story brought an important perspective to the awareness campaign, highlighting the need to recognize that men are also at risk of breast cancer and should not ignore unusual changes in their breast tissue.

    The need for inclusive breast cancer awareness remains critical, as the disease, although rare among men, can affect them too. Men should therefore be equipped with the necessary information to recognise potential warning signs and seek timely medical attention.

    Cancer Warriors Group Sharing Their Cancer Journeys and Experiences.

    The National Cancer Institute of Kenya (NCI-K) and the County Government of Nyamira, together with other partners, collaborated to hold the commemoration. Throughout the week, NCI-K has been offering free cancer screening services, which included breast, cervical, and prostate cancer screening, as well as cancer awareness education.

    The exercise sought to strengthen public awareness, promote early diagnosis, and encourage communities to take an active role in cancer prevention and control.

    Bundi’s experience as a breast cancer warrior and survivor highlights the importance of broadening public understanding of breast cancer and dispelling the misconception that the disease affects women alone. Although breast cancer is rare among men, they too are at risk and should be informed about the disease, its possible warning signs, and the importance of seeking timely medical attention.

    His story serves as a call to action for men to take a proactive approach to their health, remain alert to unusual changes in their breasts, including lumps, swelling, or changes in the nipple, and seek medical assessment without delay. Men are also encouraged to take advantage of available cancer awareness and screening initiatives rather than assume they are not at risk.

    Through partnerships with county governments and other stakeholders, NCI-K continues to advance cancer awareness, promote access to screening services and strengthen early detection efforts across the country.

    As Kenya continues to strengthen its fight against cancer, stories such as Bundi’s remind us that awareness, early detection, and access to timely care can make a difference.

    Know Your Risk. Get Screened. Act Early.

  • NCI-K CEO Dr. Elias Melly Delivers Keynote Address at International Cancer Registries Conference in Tanzania

    Arusha, Tanzania | 14–16 October 2026

    The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, delivered a keynote address at the IACR–AFCRN–NORA Scientific Conference held at Mount Meru Hotel in Arusha, Tanzania, from 14 to 16 October 2026.

    NCI-K CEO, Dr. Elias Melly Delivery his Keynote Address at the IACR, Tanzania.

    Dr. Melly was featured as the keynote speaker on the opening day of the conference, on 14 October 2026, underscoring Kenya’s participation in regional and international efforts to strengthen cancer prevention and control through research, reliable cancer data and effective surveillance systems.

    The scientific conference brought together cancer registry professionals, researchers and public health experts to share scientific evidence, exchange knowledge and discuss approaches to improving cancer registration, surveillance, research and the use of cancer data to inform policy and public health interventions.

    Strengthening Regional and International Partnerships in Cancer Control

    The conference provided a platform for collaboration among the International Association of Cancer Registries (IACR), the African Cancer Registry Network (AFCRN) and NORA, alongside scientific sessions involving NORA–REACCT–CAN. These collaborative platforms brought together expertise and research from across Africa and other regions to address shared challenges in cancer registration and control.

    Dr. Melly (centre)with outgoing IACR President, Dr. Charles Wiggins (right), and the incoming president, Dr. Dabber Wanna (left)

    For NCI-K, participation in such regional and international scientific engagements reinforces the importance of partnerships in strengthening cancer surveillance, building institutional capacity and generating evidence to guide national cancer control priorities.

    Effective cancer control depends on access to quality, timely and reliable data on cancer incidence, mortality, survival and patterns of diagnosis. Strong cancer registration systems help governments and health institutions understand the burden of cancer, identify gaps in services, plan interventions and assess progress in prevention, early detection, treatment and care.

    The conference programme featured discussions on population-based cancer registration, cancer registry governance and standards, data quality and accessibility, cervical cancer screening, cancer survival, and translating registry data into policy and public health action.

    Kenya Advances National Childhood Cancer Registry Development

    Kenya’s contribution to the scientific programme also featured work towards strengthening childhood cancer surveillance. On 15 October 2026, Gladys Chesumbai, Head of the National Cancer Registry at the National Cancer Institute of Kenya presented on “Delphi Consensus for a Standardized National Childhood Cancer Registry Minimum Dataset in Kenya.”

    Gladys Chesumbai, Head of Cancer Registry at NCI-K.

    The presentation formed part of a plenary session examining the burden of childhood, adolescent and early-onset cancers. Standardising the minimum dataset for a national childhood cancer registry is an important area of work in strengthening the consistency and quality of information collected on childhood cancers.

    Reliable childhood cancer data can support a better understanding of the disease burden, inform research and planning, and provide an evidence base for decisions aimed at improving services for children affected by cancer.

    Kenya’s participation in this scientific exchange highlights the value of sharing national experiences and learning from international expertise as the country advances its cancer surveillance and registry development agenda.

    Advancing the National Cancer Control Agenda Through Collaboration

    The conference’s focus on cancer registration, research, data standards and evidence-informed decision-making aligns with the broader need for coordinated approaches to cancer prevention and control across the region.

    As a statutory body established under the Cancer Prevention and Control Act, No. 15 of 2012, NCI-K is mandated to spearhead and coordinate cancer prevention and control in Kenya through the implementation of the National Cancer Control Strategy.

    Engagement in regional and international platforms enables the Institute to participate in scientific discussions, strengthen professional networks and contribute to collective efforts to improve cancer information systems and public health responses.

    Through continued collaboration with national, regional and international stakeholders, NCI-K remains committed to advancing evidence-informed cancer control and supporting efforts towards a cancer-free nation.

  • NCI-K Hosts AMPATH Flow Cytometry Team to Strengthen Cancer Diagnostic Services.

    NCI-K Hosts AMPATH Flow Cytometry Team to Strengthen Cancer Diagnostic Services.

    The National Cancer Institute of Kenya (NCI-K) today hosted a team from the AMPATH Flow Cytometry Program (AFCP) for a meeting with the NCI-K leadership. The team was received by the Director of the Cancer Prevention and Control Directorate, Dr. Nashat Fadhloon Noor.

    The engagement focused on strengthening collaboration and advancing cancer diagnosis through specialized laboratory technologies, including flow cytometry, which plays an important role in the diagnosis and management of several cancers, particularly haematological malignancies.

    Key areas discussed included:

    • Recognition of flow cytometry as an essential specialized cancer diagnostic service.
    • Adoption of panel-based reimbursement rather than individual antibody-based reimbursement.
    • Appropriate reimbursement for immunohistochemistry (IHC) panels.
    • Development of national technical and quality standards for specialized cancer diagnostics.
    • Establishment of coordinated specimen-referral pathways.
    • Recognition of qualified reference laboratories to support testing, training and quality assurance.

    The AMPATH delegation included Dr. Teresa Lotodo, Lead Pathologist and Chair, Pathology Department, Moi University & Medical Director, Flow Cytometry Laboratory; Raphael Koima, AFCP Program Manager/Coordinator; Dr. Gilbert Olbara, Lead Clinician and Head of Paediatric Oncology, MTRH; Dr. Ronald Tonui, Director, AMPATH Reference Laboratory; and Nicholas Kigen, Lead Laboratory Scientist, ARL.

    The meeting reaffirmed the importance of strategic partnerships, innovation and strengthened diagnostic capacity in improving early and accurate cancer diagnosis and ultimately advancing Kenya’s cancer response.

    NCI-K remains committed to building partnerships that strengthen cancer prevention, diagnosis, treatment and care towards a cancer-free nation.